Coumarin-based dual kinase inhibitors targeting CDK6 and VEGFR-2: experimental and computational validation
RSC Advances · 2026 · 16 (40) · 46094-46114
DOI: 10.1039/d6ra04693b ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Hazem Elkady und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University Cairo 11884 Egypt hazemelkady@azhar.edu.…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Princess Nourah Bint Abdulrahman University.
Abstract (Originalsprache)
A novel coumarin derivative (7e) was identified as a dual CDK6/VEGFR-2 inhibitor with potent enzymatic activity, apoptosis induction, cell cycle arrest, and anti-migratory effects, supported by docking, molecular dynamics, and DFT studies.
Autor:innen und Institutionen
- Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University Cairo 11884 Egypt hazemelkady@azhar.edu.eg Ibrahimeissa@azhar.edu.eg.
- Department of Chemistry, Faculty of Science, Al-Azhar University Nasr City Cairo Egypt walidebaied.sci85@azhar.edu.eg.
- Chemistry Department, Faculty of Science, New Valley University El-Kharja 72511 Egypt dalal_husein@sci.nvu.edu.eg.
- Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University P. O. Box 84428 Riyadh 11671 Saudi Arabia haalghulikah@pnu.edu.sa GNAlShahrani@pnu.edu.sa.
- Physics Department, Faculty of Science, Alexandria University Alexandria Egypt FatmaGalal_pg@alexu.edu.eg.
- Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University Cairo 11884 Egypt ametwaly@azhar.edu.eg.
ORCID-Profile: Hazem Elkady, Walid E Elgammal, Ibrahim H Eissa, Ahmed M Metwaly, Eslam B Elkaeed
Förderung
- Princess Nourah Bint Abdulrahman University
Zitieren
APA
Elkady, H., Elgammal, W. E., Eissa, I. H., Husein, D. Z., Al-Ghulikah, H. A., Alshahrani, G. N., Amin, F. G., Metwaly, A. M., & Elkaeed, E. B. (2026). Coumarin-based dual kinase inhibitors targeting CDK6 and VEGFR-2: experimental and computational validation. RSC Advances, 16(40), 46094-46114. https://doi.org/10.1039/d6ra04693b
Vancouver
Elkady H, Elgammal WE, Eissa IH, Husein DZ, Al-Ghulikah HA, Alshahrani GN, et al. Coumarin-based dual kinase inhibitors targeting CDK6 and VEGFR-2: experimental and computational validation. RSC Advances. 2026;16(40):46094-46114. doi:10.1039/d6ra04693b
BibTeX
@article{Elkady2026,
author = {Elkady, Hazem and Elgammal, Walid E and Eissa, Ibrahim H and Husein, Dalal Z and Al-Ghulikah, Hanan A and Alshahrani, Ghalbaa N and Amin, Fatma G and Metwaly, Ahmed M and Elkaeed, Eslam B},
title = {Coumarin-based dual kinase inhibitors targeting CDK6 and VEGFR-2: experimental and computational validation},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {40},
pages = {46094--46114},
doi = {10.1039/d6ra04693b}
}
EUVIMED